• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

MedMen sees traction in California despite market challenges

Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.
By STEVE GELSI Aug 17, 2018 | 03:15 PM EDT
Stocks quotes in this article: MMNFF

MedMen Enterprises Inc.  (MMNFF)  said that early sales in California met expectations, as the Los Angeles cannabis producer and retailer signals some success in what's been a sluggish roll-out in the state's colossal adult use cannabis business.

Although it's the currently largest adult use cannabis market in the world -- outstripping Canada's entire national demand -- local licensing efforts and competition from illegal sales stalled California's industry, market players say.

MedMen on Thursday said its systemwide revenue for the fourth quarter ending June 30 totaled $19.2 million, describing it as "strong" and offering a glimpse of its store economics in the Southern California market. 

The company said excluding its Abbot Kinney store in Southern California, which opened in early June, its other seven LA region retail booked $17.4 million quarterly revenue and an average $77.76 spend per transaction. Its average retail market markup over wholesale was 90%. About 130,000 customers returned from the previous quarter, and it gained 94,000 new customers. The company will provide full, audited fourth-quarter results in October.

MedMen spokesman Daniel Yi told Real Money the results matched company expectations. While some local jurisdictions have stalled, LA's local license issuance, where MedMen mostly operates, has been worked out for much of the year, he said.

Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.

But MedMen and other companies continue to face competition from lower black market prices. The state's also collected less tax revenue than expected.

The California Department of Tax and Fee Administration (CDTFA) on Wednesday said second-quarter cannabis industry tax revenue totaled $74 million, up from $60.9 million in the first quarter. The combined $134.9 million six-month take missed Gov. Jerry Brown's office's $175 million projection.

Karnes said California's legal cannabis -- and its tax revenue -- would gain traction over time as illegal sales slowly phase out in the state.

"It's going to take time for the illicit market to transition into the legal market," Karnes said. "Law enforcement will take measures so that the illicit market continues to face disruption. Illegal sales are a hiccup, but it'll eventually be rationalized, and we'll see the full potential of the California market."

All told, the legal marijuana business has been expected to be one of California's fastest growing industries for the next five years, according to market data. The market is expected to reach $10 billion by about 2025, according to market sources cited in MedMen's public filings.

A study released Aug 8 by cannabis delivery service Eaze said 84% of Californians are very satisfied with the legal market thus far, but that one in five state residents has purchased cannabis from the illicit market in the past three months. The survey also concluded that a 5% decrease in the overall tax rate in California could drive 23% of illicit market supporters into the legal market.

To entice more buyers from unregistered stores, the state Legislature has been considering a measure to reduce the cannabis excise tax to 11% from 15%, but so far nothing has been decided.

For its part in California and elsewhere, MedMen plans to grow its own cannabis supply and integrate production with its retailing arm. It recently opened a 45,000-square-foot cultivation and manufacturing facility in northern Nevada. It's using the same design for a Desert Hot Springs, California facility expected online by early 2019. The company plans to build similar factories in New York, and possibly Florida.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Regulation | Markets | Healthcare | Consumer Staples | Consumer Discretionary | Earnings | Consumer | Executive Interview | Gaming | E-Commerce | Stocks

More from Healthcare

UnitedHealth Group's Charts Look Strong

Bruce Kamich
Apr 16, 2021 11:35 AM EDT

Here's where traders should look to buy a pullback.

Cigna Has Made a Huge Upside Breakout

Bruce Kamich
Apr 16, 2021 10:55 AM EDT

Traders could go long CI at current levels, and we have two price objectives.

Jim Cramer: We've Got a Boom ... and a Bust

Jim Cramer
Apr 15, 2021 3:36 PM EDT

Let's look at this impossible move on the market -- and why health care could be coming off life support.

TransMedics Group's Charts Are Pointed Lower

Bruce Kamich
Apr 15, 2021 9:30 AM EDT

These charts are not pretty.

A Subscriber Asks About 2 Biotech ETFs and Here's What We Found

Bruce Kamich
Apr 14, 2021 1:05 PM EDT

Traders and investors could go long IBB or XBI at current levels and look to add on strength.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:05 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How recency bias and the Pareto Principle impact y...
  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login